We are live on
!
Find out more
RFC
Russell Frank Company Portfolio holdings
AUM
$56.9B
1-Year Est. Return
2.13%
This Fund
S&P 500
This Quarter
Est. Return
+0.49%
1 Year Est. Return
+2.13%
3 Year Est. Return
+42.95%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$62.3B
AUM Growth
+$7.85B
(+14%)
Cap. Flow
+$8.31B
Cap. Flow
% of AUM
13.34%
Top 10 Holdings %
Top 10 Hldgs %
9.97%
Holding
3,191
New
223
Increased
1,928
Reduced
784
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$168M |
| 2 |
Wells Fargo
WFC
|
+$139M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$129M |
| 4 |
Johnson & Johnson
JNJ
|
+$124M |
| 5 |
ExxonMobil
XOM
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Perrigo
PRGO
|
+$77M |
| 2 |
TSMC
TSM
|
+$47M |
| 3 |
Franklin Resources
BEN
|
+$46.8M |
| 4 |
AET
Aetna Inc
AET
|
+$44.4M |
| 5 |
Archer Daniels Midland
ADM
|
+$43.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.12% |
| 2 | Healthcare | 12.77% |
| 3 | Technology | 11.87% |
| 4 | Industrials | 11.15% |
| 5 | Consumer Discretionary | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Cardiff Oncology
CRDF
$74.7M
| $1.08M | ﹤0.01% |
+1,476
| New | +$1.05M |
|
2252
National CineMedia
NCMI
$376M
| $1.08M | ﹤0.01% |
+6,747
| New | +$1.07M |
|
|
EGN
2253
DELISTED
Energen
EGN
| $1.08M | ﹤0.01% |
15,768
+9,460
| +150% | +$658K |
|
|
BMCH
2254
DELISTED
BMC Stock Holdings, Inc
BMCH
| $1.07M | ﹤0.01% |
+54,781
| New | +$1.03M |
|
|
QLIK
2255
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
| $1.07M | ﹤0.01% |
30,638
+830
| +3% | +$29.4K |
|
2256
DigitalBridge
DBRG
$2.95B
| $1.07M | ﹤0.01% |
14,470
-1,453
| -9% | -$123K |
|
2257
Watts Water Technologies
WTS
$13.1B
| $1.07M | ﹤0.01% |
20,578
+2,705
| +15% | +$147K |
|
2258
Medifast
MED
$140M
| $1.07M | ﹤0.01% |
32,984
-43,003
| -57% | -$1.36M |
|
2259
Calix
CALX
$2.4B
| $1.06M | ﹤0.01% |
140,015
-23,696
| -14% | -$193K |
|
|
MLNX
2260
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $1.06M | ﹤0.01% |
+21,897
| New | +$1.06M |
|
|
MRTX
2261
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.06M | ﹤0.01% |
+33,774
| New | +$995K |
|
2262
Tandem Diabetes Care
TNDM
$1.53B
| $1.06M | ﹤0.01% |
+9,761
| New | +$1.21M |
|
|
2263
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.67B
| $1.06M | ﹤0.01% |
900
| – | – |
|
2264
Extreme Networks
EXTR
$3.2B
| $1.06M | ﹤0.01% |
392,699
+43,237
| +12% | +$117K |
|
2265
Heron Therapeutics
HRTX
$75.3M
| $1.06M | ﹤0.01% |
33,884
-23,570
| -41% | -$443K |
|
2266
UFP Industries
UFPI
$5.14B
| $1.06M | ﹤0.01% |
60,849
+40,566
| +200% | +$743K |
|
2267
Anika Therapeutics
ANIK
$294M
| $1.05M | ﹤0.01% |
31,900
+12,720
| +66% | +$454K |
|
2268
Old Republic International
ORI
$10.3B
| $1.05M | ﹤0.01% |
67,438
-4,315
| -6% | -$66.5K |
|
2269
Chegg
CHGG
$99.5M
| $1.05M | ﹤0.01% |
134,085
| – | – |
|
|
MODN
2270
DELISTED
MODEL N, INC.
MODN
| $1.05M | ﹤0.01% |
+88,235
| New | +$1.05M |
|
|
ARC
2271
DELISTED
ARC Document Solutions, Inc.
ARC
| $1.05M | ﹤0.01% |
+137,800
| New | +$1.12M |
|
2272
Black Hills Corp
BKH
$5.66B
| $1.05M | ﹤0.01% |
23,998
+4,173
| +21% | +$200K |
|
2273
TherapeuticsMD
TXMD
$24M
| $1.04M | ﹤0.01% |
+2,657
| New | +$937K |
|
2274
Community Trust Bancorp
CTBI
$1.4B
| $1.04M | ﹤0.01% |
29,916
+3,579
| +14% | +$119K |
|
|
S
2275
DELISTED
Sprint Corporation
S
| $1.04M | ﹤0.01% |
228,274
+91,042
| +66% | +$438K |
|
Similar funds
VRS
ACM
BKBG
CAM
FMA
KG
NPIT
AIA
Russell Frank Company's Q2 2015 Portfolio in Review
As of Q2 2015, Russell Frank Company held 3,191 positions worth $62.3B, up 14% from $54.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Russell Frank Company deployed $8.31B of net new capital in Q2 2015, opening 223 new positions and adding to 1,928 existing holdings. Its largest new stake was iShares MBS ETF: 686,878 shares worth $74.7M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Perrigo, an estimated $77M trimmed.
- Russell Frank Company's largest Q2 2015 buy was iShares MBS ETF: 686,878 shares worth $74.7M.
- Russell Frank Company added most to Merck in Q2 2015, an estimated $168M increase.
- Russell Frank Company's biggest Q2 2015 reduction was Perrigo, cutting an estimated $77M.
- Russell Frank Company fully exited USB AG (NEW) in Q2 2015, selling an estimated $19.9M.
- Russell Frank Company's ten largest holdings make up 10% of its $62.3B portfolio in Q2 2015.
- Russell Frank Company opened 223 new positions and closed 153 in Q2 2015.
- Russell Frank Company's portfolio value rose 14% quarter-over-quarter to $62.3B.
Based on Russell Frank Company's 13F filing for Q2 2015, filed 13 Aug 2015.